WHO prequalifies arthritis drug for severe COVID cases

Oncology dietitians rarely ask cancer patients about food insecurity, study finds
11 February 2022
China gives conditional approval for Pfizer COVID pill: drug regulator
12 February 2022

WHO prequalifies arthritis drug for severe COVID cases

The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe COVID-19, in a bid to increase access to the pricey drug.

Comments are closed.